257 drug price adjustments, 277 into the price linkage catalog!

A few days ago, the Hunan Provincial Public Resources Trading Center issued the "Notice on Adjusting the Price Limit of Some Drugs in Inter-Provincial Price Linkage in 2022" (hereinafter referred to as the "Notice", please click to read the original text for details )

From the perspective of the industry, Hunan Province has launched a drug price limit listing, which is intended to solve the inflated drug prices and rectify the order of the pharmaceutical market

Which varieties make it into the list?

It can be seen from the list of drugs included in the price linkage catalogue that this time Hunan Province will mainly list the national emergency rescue drugs, pediatric non-medical drugs that are on the Internet before January 1, 2021 and have no purchase and distribution records from January 1 to December 31, 2021.

Among them, naloxone hydrochloride injection is currently the most widely used opioid receptor antagonist in clinical practice

The reporter also noticed that a number of proprietary Chinese medicines have been included in the list of drugs in the price linkage catalog, including Bupleurum injection, Huoxiangzhengqi mixture, Huoxiangzhengqi water, and Xiaoer Kechuanling granules

According to data from Minet.

Angong Niuhuang Wan is also on the list

In addition, a total of 257 drugs were included in the list of price-limited drugs linked to the price adjustment and linked to the price list

According to the requirements of the document, deferasirox dispersible tablets are "dual-channel" negotiated drugs in Hunan Province and are produced by Novartis
.
The drug is temporarily recalled to the online price before February 28, 2022, which is 19.
8 yuan.
After the price linkage, it will be determined to restore to the negotiated price according to the situation of other provinces
.

Dynamic adjustment will be normalized

In fact, Hunan Province’s adjustment to the list and prices of drugs linked to the price linked online and linked to the Internet is based on the “Notice on Launching the Inter-provincial Drug Price Linked Listing Work in 2022” issued by the Hunan Provincial Medical Security Bureau in late March this year ( Hunan Medical Insurance [2022] No.
14) work arrangement
.

In this 2022 inter-provincial drug price linkage work notice, there are only two categories of drugs that can be excluded from the linkage scope : one is drugs with special policies, including fixed-point supply, national negotiation during the agreement period, and centralized procurement of drugs.
(Including national procurement, inter-provincial centralized procurement, and Hunan special antibacterial drug centralized procurement) and the same generic name and the same tendered dosage form of drugs that have been listed on the Internet at a limited price; one category is the drugs that have been suspended or withdrawn from the Internet
.

When specifically setting the price linkage rules, Hunan divided the drugs listed on the Internet into four categories: national negotiated drugs and their generic drugs, basic infusions, first aid and shortage drugs, and linked catalog drugs
.
The price linkage rules are clear.
During the agreement period, the state-negotiated drugs and their generic drugs shall be negotiated at a price not higher than the current lowest effective online price, actual transaction price, and the same generic name and the same dosage form of the manufacturer's drug on the national provincial-level procurement platform.
Low-value linked listings are included in the management of linked listings
.
Drugs negotiated by the state upon the expiration of the agreement shall be linked to the Internet according to the requirements of the “Linked List of Drugs” in this notice, and shall be included in the linked list management
.
For basic large-scale infusions, drugs that have been listed on the Internet will be linked to the Internet at a low value that is not higher than the current lowest effective online price and actual transaction price of the manufacturer's drug national provincial procurement platform
.
According to the requirements, the national emergency (rescue), pediatric generic drug demonstration catalog drugs, and shortage drugs, the manufacturer independently applies for listing and provides the lowest current online (transaction) price of the drug in the three provinces in the country, as a reference for medical institutions to negotiate, and Implement dynamic management according to relevant policies and the situation of hanging on the network
.

For the drugs in the linkage catalogue, the generic names and dosage forms of chemical drugs and biological preparations are not listed on the provincial procurement platform, which can meet the requirements of 8 other provincial procurement platforms, or meet the requirements of 5 other provincial procurement platforms and 5 in the province.
For medical institutions at level 2 and above that have purchase records on the provincial procurement platform, the price shall not be higher than the current lowest online price and the actual transaction price of the drug on the national provincial procurement platform, and shall not be higher than that of the generic name and the same medical insurance dosage form.
1.
8 times of the highest unit comparable price of drugs listed on the Internet can apply for linkage to the Internet
.

Some people in the industry believe that the policy trend of Hunan Province's launch of drug price capping and listing seems to be more inclined to collect real drug transaction low prices
.
In his view, if the lowest price at the real transaction level is directly linked, it may further squeeze out the water in the field of drug purchase and sales
for the current online drugs .